Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-15-008231
Filing Date
2015-11-05
Accepted
2015-11-05 16:54:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO REGISTRATION STATEMENT fs32015a1_immucellcorp.htm S-3/A 260128
2 OPINION OF PIERCE ATWOOD LLP fs32015a1ex5i_immucellcorp.htm EX-5.1 31565
3 CONSENT OF BAKER NEWMAN & NOYES, LLC fs32015a1ex23ii_immucellcorp.htm EX-23.2 4314
  Complete submission text file 0001213900-15-008231.txt   296947
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-207635 | Film No.: 151201430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances